1 Absorption, distribution, metabolism, and excretion (ADME) of 14C-sonidegib (LDE225) in healthy volunteers. Cancer Chemother Pharmacol. 2014 Jul;74(1):63-75. doi: 10.1007/s00280-014-2468-y. Epub 2014 May 10.
2 Accelerator mass spectrometry-enabled studies: current status and future prospects. Bioanalysis 2(3), 519–541 (2010).
3 Assessment of the absorption, metabolism and excretion of [14C]pasireotide in healthy volunteers using accelerator mass spectrometry. Cancer Chemother Pharmacol. 2013 Jul;72(1):181-8. doi: 10.1007/s00280-013-2183-0. Epub 2013 May 17.
4 Cidofovir: a novel antitumor agent for glioblastoma. Clin Cancer Res. 2013 Dec 1;19(23):6473-83.
5 Intrinsic Erythrocyte Labeling and Attomole Pharmacokinetic Tracing of 14C-Labeled Folic Acid with Accelerator Mass Spectrometry. Analytical Biochemistry 269, 348–352 (1999).
8 Performance Evaluation of the New AMS System at Accium BioSciences. Radiocarbon, Vol 49, Nr 1, 171–180 (2007).
6 Precision and Accuracy in the Quantitative Analysis of Biological Samples by Accelerator Mass Spectrometry: Application in Microdose Absolute Bioavailability Studies. Analytical Chemistry., 83 (14), pp 5607–5616 (2011) with supporting information.
7 A pro-convulsive carbamazepine metabolite: Quinolinic acid in drug resistant epileptic human brain. Neurobiology of disease. 2012;46(3):692-700. doi:10.1016/j.nbd.2012.03.010.
9 Simultaneous AMS determination of 14C content and total carbon mass in biological samples. Nuclear Instruments and Methods in Physics Research B 268 (2010) 1307–1308.
